4-phenylbutyl isothiocyanate has been researched along with sulforaphane in 2 studies
Studies (4-phenylbutyl isothiocyanate) | Trials (4-phenylbutyl isothiocyanate) | Recent Studies (post-2010) (4-phenylbutyl isothiocyanate) | Studies (sulforaphane) | Trials (sulforaphane) | Recent Studies (post-2010) (sulforaphane) |
---|---|---|---|---|---|
8 | 0 | 2 | 1,754 | 65 | 1,317 |
Protein | Taxonomy | 4-phenylbutyl isothiocyanate (IC50) | sulforaphane (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 9 | |
Macrophage migration inhibitory factor | Homo sapiens (human) | 2.2 | |
Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, FL; Di Pasqua, AJ; Fine, RL; Govind, S; Hong, C; Mao, Y; McCracken, E; Mi, L; Tomita, Y; Wang, X; Woodrick, JC; Wu, JY | 1 |
Dale, EJ; Gamble, AB; Gommans, AL; Hampton, MB; Nakatani, Y; Rutledge, MT; Smith, RA; Spencer, ES; Tyndall, JD; Vo, CT; Wilbanks, SM | 1 |
2 other study(ies) available for 4-phenylbutyl isothiocyanate and sulforaphane
Article | Year |
---|---|
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
Topics: Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cysteine; Drug Screening Assays, Antitumor; Humans; Isothiocyanates; Mutation; Protein Conformation; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2011 |
Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
Topics: Drug Design; Enzyme Inhibitors; Humans; Intramolecular Oxidoreductases; Isothiocyanates; Jurkat Cells; Macrophage Migration-Inhibitory Factors; Molecular Docking Simulation; Protein Binding; Protein Conformation | 2015 |